Superconductor technologies inc (SCON)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-7,973

-9,229

-9,563

-9,357

-8,288

-8,131

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-10,981

-10,480

-9,814

-8,602

-9,052

-9,091

-6,734

-8,251

-9,277

-10,319

-12,700

-12,173

-10,557

-9,365

-10,348

-10,928

-11,801

-12,868

-12,658

-13,383

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

623

820

938

933

927

1,015

-

1,192

1,408

1,640

1,885

1,877

2,010

2,127

2,139

2,262

2,366

2,311

2,458

2,265

1,916

1,729

1,332

1,329

1,352

1,372

1,276

1,055

772

481

313

375

525

660

805

0

0

0

Stock-based compensation expense

84

87

110

101

91

84

-

85

170

255

341

528

686

846

1,004

1,355

1,632

1,907

2,198

1,968

1,591

1,227

862

587

552

513

492

487

591

699

854

1,119

1,304

1,489

1,563

0

0

0

Provision for excess and obsolete inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

270

0

0

0

-

-

-

-

Write-off of intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-142

-161

-74

-844

0

0

0

Adjustments to fair value of warrant derivatives

-

-

-

-

-

52

-

84

140

135

99

212

170

159

183

1,004

1,490

2,240

4,852

4,270

4,751

3,345

480

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to warrant exercise price

-

-

-

-

-

24

-

0

0

0

-

-

-

-

-

-

-

-

537

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from sale of patents, property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

7

13

19

114

200

-143

-149

-239

-283

61

83

92

0

0

0

-

-

-

-

Write-down of intangibles

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obsolete inventory

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss from investment in Resonant LLC joint venture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Equity loss from Resonant LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Accounts receivable

0

-

-

-

-181

-151

-

22

558

182

143

82

-15

-69

-28

-28

-20

37

-45

5

-239

-272

80

-95

46

-34

-116

-652

-51

162

61

694

175

-398

-46

0

0

0

Inventories

160

90

-3

49

-72

70

-

103

90

116

34

-18

1

-110

-52

-54

62

164

105

91

-9

-21

-2

-6

-40

-66

25

-498

-957

-1,034

-1,289

-824

-253

212

96

0

0

0

Prepaid expenses and other current assets

125

16

20

5

-5

-22

-

-37

-3

-4

-26

41

30

-163

-12

-35

-149

-75

-236

12

133

-71

-79

-318

-134

101

122

-70

-230

-209

-159

205

260

210

127

0

0

0

Patents and licenses

-

-

-

-

-

-14

-

-22

-140

-252

-212

-189

-35

121

130

201

184

172

128

73

66

56

70

150

164

157

160

106

122

252

199

189

135

-6

66

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-27

-29

-29

67

-32

-31

-34

-222

-128

-131

-131

-62

-62

92

127

148

148

-4

-38

-39

-9

171

150

152

152

0

0

0

Accounts payable, accrued expenses and other current liabilities

-51

-41

-166

16

-110

12

-

15

99

96

-132

-97

-224

-125

-9

-37

-107

-461

-456

-379

-435

-713

-225

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

257

-191

-125

-53

0

0

0

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-8,241

-7,910

-8,161

-8,484

-9,100

-9,855

-10,202

-10,025

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash used in operating activities

-8,246

-8,803

-8,732

-7,792

-7,126

-6,931

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-10,911

-10,668

-10,148

-10,018

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

-

-

-

-

-

189

-

0

0

0

-

-

-

-

-

-

-

95

141

325

940

2,253

3,704

4,129

3,542

2,137

818

969

1,906

2,800

3,588

3,042

3,470

3,185

2,254

0

0

0

Net proceeds from the sale of patents, property and equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

0

-

-

-

0

1

1

1

1

96

187

188

188

98

55

61

83

92

0

0

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

-140

3,003

2,388

1,075

-281

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common shares for withholding obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120

135

134

154

303

0

0

0

Net cash provided in investing activities

0

-

-

-

-184

-189

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-2,729

-3,164

-2,901

-1,985

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common, prefunded warrants and preferred stock

-

-

-

-

-

9,680

-

0

0

0

-

-

-

-

-

-

-

0

-

-

0

0

-

-

-

-

-

-

-

-

9,311

6,621

6,621

6,621

12,402

0

0

0

Net proceeds from the exercise of warrants

0

-

-

-

0

-

-

-

-

-

200

0

0

0

-

-

-

0

1,687

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,572

14,855

6,283

6,617

6,617

4,085

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

5,288

3,900

1,421

9,401

7,980

9,680

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,486

6,487

6,467

12,099

0

0

0

Net increase (decrease) in cash and cash equivalents

-1,746

-4,903

-7,311

1,425

670

2,560

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

2,231

662

316

6,231

186

-850

-2,510

-6,221

-9,289

1,992

6,112

3,825

7,765

-3,757

-7,874

-2,531

-7,154

-7,345

-6,582

96

0

0

0

Warrant liability converted to capital in excess of par

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-